|Generic name||Mechlorethamine gel|
|Brand name(s), other common name(s)||ValchlorTM|
|Drug type||Alkylating drug|
|How the drug is given||Topical|
Indications and Usage
Mechlorethamine gel is FDA approved for the treatment of Stage 1A and 1B mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Side effects needing medical attention
Skin inflammation; itchy skin; bacterial skin infection; skin ulceration or blistering; skin hyperpigmentation
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.